Long-acting growth hormone dosage forms with superior efficacy to daily somatropin
US12303553B2 · kind B2 · utility
0Cited by
20References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 3, 2020 |
| Grant date | May 20, 2025 |
| Priority date | — |
| Expiry date | Dec 31, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A long-acting growth hormone or a pharmaceutical formulation comprising such long-acting growth hormone for use in a method of treating growth hormone deficiency with improved outcomes is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.